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Active Bacterial Core Surveillance (ABCs) Report 
Emerging Infections Program Network 
Streptococcus pneumoniae, 2017
ABCs Areas 
California (3 county San Francisco Bay area); Colorado (5 
county Denver area); Connecticut;  Georgia (20 county 
Atlanta area); Maryland (6 county Baltimore area); 
Minnesota; New Mexico; New York (15 county Rochester 
and Albany areas and children <5 years in Erie county); 
Oregon (3 county Portland area); Tennessee (20 counties).  
  
ABCs Population 
The surveillance areas represent 34,293,143 persons. 
Source: National Center for Health Statistics bridged-race 
vintage 2017 postcensal file 
 
ABCs Case Definition 
Invasive pneumococcal disease: isolation of Streptococcus 
pneumoniae from normally sterile site in resident of a 
surveillance area in 2017.  
 
ABCs Methodology 
ABCs personnel routinely contacted all microbiology 
laboratories serving acute care hospitals in their area to 
identify cases. Standardized case report forms that include 
information on demographic characteristics, clinical 
syndrome, and outcome of illness were completed for each 
identified case. WGS based characterization was 
conducted on all pneumococcal isolates, which includes 
deduction of capsular serotype and MIC predictions 
(including PBP typing system for determining beta lactam 
antibiotic MICs). Conventional MIC testing is conducted 
on selected strains. Regular laboratory audits assessed 
completeness of active surveillance and detected additional 
cases.  
 
Rates of  invasive pneumococcal disease were calculated 
using population estimates for 2017 from the bridged-race 
vintage 2017 postcensal file. For national estimates, 
race- and age-specific rates of disease were applied from 
the aggregate surveillance area to the age and racial 
distribution of the 2017 U.S. population.  Cases with 
missing data, excluding ethnicity, were multiply imputed 
using sequential regression imputation methods.¶ 
 
Reported ABCs Profiles 
Race    No.    (Rate*) 
White  2,234  (8.8) 
Black  798  (13.9) 
Other   223  (6.8) 
 
*Per 100,000 population for ABCs areas 
 
¶ Surveillance Note 
 Missing race (n=301) data were multiply imputed using 
sequential regression imputation methods.  
 
+ Penicillin CLSI breakpoints changed in 2009 
 
 Cases Deaths 
Age (years)      No.       (Rate*)  No.           (Rate*) 
< 1  48  (11.6) 3 (0.72) 
1  33  (7.9) 2 (0.48) 
2-4  66  (5.2) 4 (0.32) 
5-17  86  (1.5) 6 (0.11) 
18-34  203  (2.5) 14 (0.17) 
35-49  411  (6.1) 30 (0.44) 
50 64  1,116  (16.6) 125 (1.86) 
65-74  618  (20.8) 82 (2.76) 
75-84  407  (29.3) 44 (3.16) 
≥ 85  267  (41.8) 61 (9.56) 
Total  3,255  (9.5) 371 (1.08) 
*Per 100,000 population for ABCs areas 
Syndrome     No.               (%*) 
Meningitis 226          (6.9) 
Bacteremia without focus 533     (16.4) 
Pneumonia with bacteremia 2,254     (69.3) 
 
* Percent of cases 
Antibiotic    
Susceptibility S* I† R‡ 
Penicillin+ 96.0 1.7 2.4 
Cefotaxime 97.9 1.8 0.3 
Erythromycin 70.7 0.0 29.3 
TMP/Sulfa 82.0 11.1 6.9 
Tetracycline 88.7 0.0 11.3 
Levofloxacin 99.9 0.0 0.1 
Vancomycin 100 0.0 0.0 
 
Based on reference lab testing of 2,897 isolates.  
* Susceptible; † Intermediate; ‡ Resistant based on year 2017 
CLSI definitions 
 
National Estimates of Invasive Disease 
 Cases:  31,000   (9.5/100,000) 
 Deaths:    3,590   (1.10/100,000) 
  
Healthy People 2020 Update 
Objective: Decrease the incidence of invasive pneumococcal 
infections to 12 per 100,000 persons less than 5 years of age 
and to 31 per 100,000 persons aged 65 and older. 
Age (year) 2020 Objective  2017 Rate* 
< 5     12/100,000         7/100,000 
≥ 65     31/100,000       26/100,000 
*Per 100,000 U.S. population < 5 years or ≥ 65 years 
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